Discover investment opportunities in Best Medical Stocks Under $10 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best Medical Stocks Under $10 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best Medical Stocks Under $10 using our Smart AI Filter.
8 stocks found for "Best Medical Stocks Under $10"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.48 Risk measure | ±100.0% Price volatility | -0.7 Valuation | 0.00% Annual yield | |||
0.93 Risk measure | ±63.0% Price volatility | -1.1 Valuation | 0.00% Annual yield | |||
2.28 Risk measure | ±98.6% Price volatility | -3.0 Valuation | 0.00% Annual yield | |||
1.39 Risk measure | ±70.2% Price volatility | -9.4 Valuation | 0.00% Annual yield | |||
2.26 Risk measure | ±100.0% Price volatility | -7.6 Valuation | 0.00% Annual yield | |||
1.14 Risk measure | ±68.4% Price volatility | 37.8 Valuation | 0.00% Annual yield | |||
0.40 Risk measure | ±100.0% Price volatility | -0.7 Valuation | 0.00% Annual yield | |||
0.78 Risk measure | ±100.0% Price volatility | -5.7 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Ocular Therapeutix (OCUL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Read moreBluebird Bio (BLUE) came out with a quarterly loss of $2.66 per share versus the Zacks Consensus Estimate of a loss of $3.60. This compares to loss of $7.20 per share a year ago.
Read moreCoherus BioSciences (CHRS) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.32 per share a year ago.
Read moreNeoGenomics (NEO) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.02 per share a year ago.
Read moreNautilus Biotechnology (NAUT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read moreHere is how Cabaletta Bio, Inc. (CABA) and KalVista Pharmaceuticals, Inc. (KALV) have performed compared to their sector so far this year.
Read more